ASH Clinical News July 2017 V2 | Page 7
VOLUME 03 | NUMBER 08 | JULY 2017
Around the Network
AMERICAN SOCIETY OF HEMATOLOGY (ASH)
HEADQUARTERS
2021 L Street NW, Suite 900
Washington, DC 20036
www.hematology.org
Tel: 202-776-0544
IN THIS ISSUE
EDITOR-IN-CHIEF
Mikkael Sekeres, MD, MS drawing first blood
Is MRD Testing Worthwhile
in Myeloma?
ASSOCIATE EDITORS The ability to measure minimal residual disease (MRD)
after therapy has the potential to help guide treatment
decisions and predict patients’ likelihood of relapse, but is
MRD monitoring ready to be used in routine clinical prac-
tice? Faith Davies, MD, and Saad Z. Usmani, MD, debate
the question, “Is measuring MRD worthwhile in myeloma?”
Vice-Chair for Clinical Research
Director, Leukemia Program
Cleveland Clinic, Taussig Cancer Institute
Cleveland, OH
Beth Faiman, CNP, PhD 42
Alice Ma, MD clinical news
Cleveland Clinic
Cleveland, OH
University of North Carolina School of Medicine
Chapel Hill, NC
David Steensma, MD
Dana-Farber Cancer Institute
Boston, MA
Keith Stewart, MBChB, MBA
Mayo Clinic
Scottsdale, AZ
The Power of
Collaboration
Richard Pazdur, MD, director of the U.S. Food and Drug
Administration’s newly established Oncology Center of Excellence,
discusses the center’s integrative, innovative approach to
bringing hematology/oncology products to patients.
36
16 CD19-Directed CAR T-Cell Therapy in Young
Patients With ALL
23 Finding the Best VTE Prophylaxis Options for
Patients Undergoing Hip and Knee Surgery
28 On Location: Hematology Highlights from
the 2017 ASCO Annual Meeting
PUBLISHER
American Medical Communications (AMC)
EDITORIAL
MANAGING EDITORS
Kristin Hubing, ASH
Ariel Jones-DeMaio, AMC
ASSOCIATE MANAGING EDITOR
Kerri Fitzgerald, AMC
EDITORIAL ASSOCIATE
Laurie Adamson, ASH
ART DIRECTOR
Ari Mihos
ASSISTANT ART DIRECTORS
Charlene DePrizio
John Salesi
DIGITAL PROJECTS MANAGER
Chris Gedikli
ASHCLINICALNEWS.ORG @ASHCLINICALNEWS
Did you miss any of the hematology
highlights reported at the 2017
ASCO Annual Meeting? Visit
ashclinicalnews.org/meeting-
coverage to watch all of our exclusive
interviews with presenters.
You can also find all of our online-
only coverage at ashclinicalnews.org/
on-location.
And, be sure to check out our
special mid-July issue for more of
our coverage of this meeting, as
well as the 22nd Congress of the
European Hematology Association. After the ASCO Annual Meeting
ends, we’ll be sharing all of our
coverage on Twitter, so stay in
the loop by following us at
@ASHClinicalNews.
Make sure to sign up
for our e-newsletters to
have the latest updates
delivered to your inbox. Visit
ashclinicalnews.org to sign up!
ADVERTISING
ACCOUNT MANAGER
Nick Luciano
[email protected]
Gene Conselyea
[email protected]
Recruitment advertising orders can be sent to:
DIRECTOR, RECRUITMENT CLASSIFIEDS
Lauren Morgan
[email protected]
Visit us at ashclinicalnews.org
Follow us on Twitter @ASHClinicalNews
©2017 by the American Society of Hematology.
All materials contained in this newsletter are protected by
copyright laws and may not be used, reproduced, or oth-
erwise exploited in any manner without the express prior
written permission of ASH Clinical News. Any third-party
materials communicated to ASH Clinical News become
its copyrighted property and may be used, reproduced, or
otherwise exploited by ASH Clinical News.
ASHClinicalNews.org
YOU MAKE THE CALL WINNER
Announcing last month’s “You Make the Call - Readers’ Response” winner:
John Maddox, MD
Hope you enjoy your prize!
For your chance to win, be sure to send in your response to each month's You Make the Call question!
Subscription inquiries should be sent to: [email protected]
All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036.
Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions
expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is as-
sumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise
or from any use or operation of any methods, products, instructions or ideas contained in the material herein.
Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does
not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by
its manufacturer.
About the American Society of Hematology
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of
the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic
and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726.
Periodicals postage is pending/paid at Manalapan, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications,
630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2016.
ASH Clinical News
5